Phase 1 Huntington Disease Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease

Huntington Disease

Hoffmann-La Roche53 enrolled5 locationsNCT06826612

Recruiting

Phase 1Phase 2

Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease

Huntington Disease

Leslie Thompson21 enrolled1 locationNCT07451613

Recruiting

Phase 1Phase 2

A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

Spinocerebellar Ataxia Type 3Spinocerebellar Ataxia Type 1Huntington Disease

Vico Therapeutics B. V.68 enrolled14 locationsNCT05822908